MEDICINES Australia (MA) has appointed Dr Anna Lavelle (pictured) as an independent Board member following a comprehensive recruitment process.
Recently retired from AusBiotech, Lavelle had served for eleven years as the ceo of the industry association which represents Australia's growing biotechnology sector.
MA chairman Wes Cook said, "Dr Lavelle is a talented, well respected person within the innovative pharmaceutical and biotechnology sector who will now bring her years of experience to our Board."
"For more than 25 years, Dr Lavelle has served on the boards of not-for-profit, government and for-profit entities."
Lavelle will also chair the soon to be created Medicines Australia Advisory Council which will be made up of senior leaders from the membership as well as leaders from the broader health science sector.
An announcement of the Advisory Council appointees will be made early in the new year, Cook said.
The above article was sent to subscribers in Pharmacy Daily's issue from 19 Dec 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Dec 16
